In 2021, the World Health Organization (WHO) reclassified isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM) and grade 4 IDH mutant astrocytoma as grade 4 diffuse gliomas [1]. Here, IDH3A is linked to glioblastoma.